Not yet recruiting
Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.
NCT07325201
- Conditions
- Acid-Base Imbalance, Acidosis, Autoimmune Diseases, +26 more
- Locations
-
- International Diabetes Center Minneapolis, Minnesota, United States